Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02938611

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

Feasibility Study on Estimating the Prevalence and Management of Stage 4 Chronic Kidney Disease in Adults Via Laboratories and Nephrologists in the Gard, France

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,375 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.

Conditions

Timeline

Start date
2019-01-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2016-10-19
Last updated
2025-03-10

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02938611. Inclusion in this directory is not an endorsement.

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France (NCT02938611) · Clinical Trials Directory